Evelo Biosciences Inc (EVLO) PT Raised to $18 at BMO Capital
Tweet Send to a Friend
BMO Capital analyst Matthew Luchini raised the price target on Evelo Biosciences Inc (NASDAQ: EVLO) to $18.00 (from $17.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
